|
**Overview**: Infertility Male Panel**Introduction**: The Infertility Male Panel is a diagnostic tool designed to assess male infertility causes using serum samples. In India, male factors contribute to ~40-50 percent of infertility cases (~13-15 million couples affected), commonly due to hypogonadism, varicocele, or obstructive azoospermia. High morbidity from under-testing in rural/low-SES men with primary infertility, limited andrology labs, delayed diagnosis leading to prolonged emotional burden or missed ICSI opportunity. Per endocrinology practices aligned with ICMR, FOGSI, and Indian Society for Assisted Reproduction guidelines, the test employs immunoassay for testosterone, FSH, LH, and prolactin over 1-2 days with high accuracy, valuable for identifying hypogonadotropic hypogonadism, primary testicular failure, or hyperprolactinemia. This diagnostic falls under reproductive screening and targets men with abnormal semen analysis or infertility >1 year, addressing accurate detection to guide testosterone replacement, clomiphene, or ART. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise hormonal evaluation and improving male reproductive outcomes. Its serum-based approach ensures reliable androgen/gonadotropin measurement.**Other Names**: Infert Male Pnl.**FDA Status**: FDA approved, CLIA certified for endocrinology/immunology, compliant with 2025 standards.**Historical Milestone**: Male infertility hormonal panel standard; in India, used in andrology clinics.**Purpose**: The test assesses 4 parameters including testosterone to guide male infertility evaluation, differentiate hypogonadism types, inform therapy.**Test Parameters**: 1. Testosterone, 2. FSH, 3. LH, 4. Prolactin.**Pretest Condition**: Fasting 10-12 hours recommended (morning sample ideal); patients should report infertility or low libido.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on semen analysis, erectile function, family history.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of untreated male infertility including prolonged childlessness, benefits of hormonal assessment, and minimal discomfort from venipuncture.**Procedural Considerations**: The test involves sample processing using immunoassay by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis, or diurnal variation can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Low testosterone + high FSH/LH indicates primary failure; low/normal FSH/LH suggests secondary, necessitating specialist input.**Specialist Consultation**: Andrologists or endocrinologists should be consulted for management.**Additional Supporting Tests**: Semen analysis, scrotal ultrasound for confirmation.**Test Limitations**: Morning sample critical; comprehensive approach required.**References**: Indian Journal of Urology 2024, Infertility Studies India 2023. |
